Target intelligence / Profile preview

Phosphate anion (Pi)

Target
Pi
Molecular classification
Inorganic ion, Anion, Other
01

Overview

Phosphate anions are essential inorganic ions required for a multitude of biological processes, including the formation of hydroxyapatite in bone, the production of cellular energy via ATP, and the structural integrity of nucleic acids and cell membranes [PubChem, 2024]. In healthy individuals, phosphate levels are tightly regulated by the kidneys through filtration and reabsorption; however, in patients with advanced chronic kidney disease (CKD), renal excretion is severely impaired, leading to hyperphosphatemia [NIH, 2023]. Elevated serum phosphate is a primary driver of secondary hyperparathyroidism and systemic vascular calcification, which significantly increases cardiovascular risk in renal patients [Kidney International, 2017]. Pharmacological management focuses on reducing the absorption of dietary phosphate using phosphate binders, which are non-absorbable agents that sequester phosphate within the gastrointestinal tract [StatPearls, 2023]. These drugs are critical for managing mineral and bone disorders and are a cornerstone of therapy for patients on dialysis.

Other names
Inorganic phosphateOrthophosphateDietary phosphatePO4 3-
02

Mechanism of action

Phosphate binders act by chelating or binding to dietary phosphate in the gastrointestinal tract, forming insoluble complexes that are excreted in the feces, thereby reducing systemic absorption [StatPearls, 2023; NIH, 2022].

03

Biological functions

Bone mineralizationEnergy metabolismSignal transductionAcid-base balanceOther
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

Gastrointestinal distress (constipation, nausea)Vascular and soft tissue calcification (with calcium-based binders)Metabolic acidosis (with sevelamer hydrochloride)Drug-drug interactions due to binding of co-administered medications
06

Interacting drugs

Sevelamer

5 more in the full profile.

07

Biomarkers

Serum phosphorus levelsFibroblast Growth Factor 23 (FGF23)Parathyroid hormone (PTH)

Beyond the preview

Go deeper on Phosphate anion (Pi).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphate anion (Pi).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call